BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33984723)

  • 1. Absence of Toll-like receptor 7 protects mice against Pseudomonas aeruginosa pneumonia.
    Xu H; Huang L; Luo Q; Tu Q; Liu J; Yu R; Huang J; Chen T; Yin Y; Cao J
    Int Immunopharmacol; 2021 Jul; 96():107739. PubMed ID: 33984723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor 9 deficiency protects mice against Pseudomonas aeruginosa lung infection.
    Benmohamed F; Medina M; Wu YZ; Maschalidi S; Jouvion G; Guillemot L; Chignard M; Manoury B; Touqui L
    PLoS One; 2014; 9(3):e90466. PubMed ID: 24595157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-27 controls sepsis-induced impairment of lung antibacterial host defence.
    Cao J; Xu F; Lin S; Song Z; Zhang L; Luo P; Xu H; Li D; Zheng K; Ren G; Yin Y
    Thorax; 2014 Oct; 69(10):926-37. PubMed ID: 25074706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surfactant proteins A and D enhance pulmonary clearance of Pseudomonas aeruginosa.
    Giannoni E; Sawa T; Allen L; Wiener-Kronish J; Hawgood S
    Am J Respir Cell Mol Biol; 2006 Jun; 34(6):704-10. PubMed ID: 16456184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage FABP4 is required for neutrophil recruitment and bacterial clearance in Pseudomonas aeruginosa pneumonia.
    Liang X; Gupta K; Quintero JR; Cernadas M; Kobzik L; Christou H; Pier GB; Owen CA; Çataltepe S
    FASEB J; 2019 Mar; 33(3):3562-3574. PubMed ID: 30462529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll/IL-1R domain-containing adaptor protein (TIRAP) is a critical mediator of antibacterial defense in the lung against Klebsiella pneumoniae but not Pseudomonas aeruginosa.
    Jeyaseelan S; Young SK; Yamamoto M; Arndt PG; Akira S; Kolls JK; Worthen GS
    J Immunol; 2006 Jul; 177(1):538-47. PubMed ID: 16785551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute exposure to silica nanoparticles enhances mortality and increases lung permeability in a mouse model of Pseudomonas aeruginosa pneumonia.
    Delaval M; Boland S; Solhonne B; Nicola MA; Mornet S; Baeza-Squiban A; Sallenave JM; Garcia-Verdugo I
    Part Fibre Toxicol; 2015 Jan; 12(1):1. PubMed ID: 25605549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-36γ and IL-36 receptor signaling mediate impaired host immunity and lung injury in cytotoxic Pseudomonas aeruginosa pulmonary infection: Role of prostaglandin E2.
    Aoyagi T; Newstead MW; Zeng X; Nanjo Y; Peters-Golden M; Kaku M; Standiford TJ
    PLoS Pathog; 2017 Nov; 13(11):e1006737. PubMed ID: 29166668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Mobility Group Box-1 mediates hyperoxia-induced impairment of Pseudomonas aeruginosa clearance and inflammatory lung injury in mice.
    Patel VS; Sitapara RA; Gore A; Phan B; Sharma L; Sampat V; Li JH; Yang H; Chavan SS; Wang H; Tracey KJ; Mantell LL
    Am J Respir Cell Mol Biol; 2013 Mar; 48(3):280-7. PubMed ID: 23087050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redundant and cooperative interactions between TLR5 and NLRC4 in protective lung mucosal immunity against Pseudomonas aeruginosa.
    Tolle L; Yu FS; Kovach MA; Ballinger MN; Newstead MW; Zeng X; Nunez G; Standiford TJ
    J Innate Immun; 2015; 7(2):177-86. PubMed ID: 25402425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitinase 3-Like 1 (Chil1) Regulates Survival and Macrophage-Mediated Interleukin-1β and Tumor Necrosis Factor Alpha during Pseudomonas aeruginosa Pneumonia.
    Marion CR; Wang J; Sharma L; Losier A; Lui W; Andrews N; Elias JA; Kazmierczak BI; Roy CR; Dela Cruz CS
    Infect Immun; 2016 Jul; 84(7):2094-2104. PubMed ID: 27141083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inescapable need for neutrophils as mediators of cellular innate immunity to acute Pseudomonas aeruginosa pneumonia.
    Koh AY; Priebe GP; Ray C; Van Rooijen N; Pier GB
    Infect Immun; 2009 Dec; 77(12):5300-10. PubMed ID: 19805527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to Pseudomonas aeruginosa chronic lung infection requires cystic fibrosis transmembrane conductance regulator-modulated interleukin-1 (IL-1) release and signaling through the IL-1 receptor.
    Reiniger N; Lee MM; Coleman FT; Ray C; Golan DE; Pier GB
    Infect Immun; 2007 Apr; 75(4):1598-608. PubMed ID: 17283089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of IL-10 on neutrophil recruitment and survival after Pseudomonas aeruginosa challenge.
    Sun L; Guo RF; Newstead MW; Standiford TJ; Macariola DR; Shanley TP
    Am J Respir Cell Mol Biol; 2009 Jul; 41(1):76-84. PubMed ID: 19097982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Toll-like receptor 5 in the innate immune response to acute P. aeruginosa pneumonia.
    Morris AE; Liggitt HD; Hawn TR; Skerrett SJ
    Am J Physiol Lung Cell Mol Physiol; 2009 Dec; 297(6):L1112-9. PubMed ID: 19801452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary immunity to Pseudomonas aeruginosa in intestinally immunized rats roles of alveolar macrophages, tumor necrosis factor alpha, and interleukin-1 alpha.
    Buret A; Dunkley ML; Pang G; Clancy RL; Cripps AW
    Infect Immun; 1994 Dec; 62(12):5335-43. PubMed ID: 7960112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination induces rapid protection against bacterial pneumonia via training alveolar macrophage in mice.
    Gu H; Zeng X; Peng L; Xiang C; Zhou Y; Zhang X; Zhang J; Wang N; Guo G; Li Y; Liu K; Gu J; Zeng H; Zhuang Y; Li H; Zhang J; Zhang W; Zou Q; Shi Y
    Elife; 2021 Sep; 10():. PubMed ID: 34544549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTEN limits alveolar macrophage function against Pseudomonas aeruginosa after bone marrow transplantation.
    Hubbard LL; Wilke CA; White ES; Moore BB
    Am J Respir Cell Mol Biol; 2011 Nov; 45(5):1050-8. PubMed ID: 21527775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 4 Deficiency Reverses Development of Secondary Pseudomonas aeruginosa Pneumonia During Sepsis-Associated Immunosuppression.
    Song Z; Zhang J; Zhang X; Li D; Wang H; Xu X; Xu W; Yin Y; Cao J
    J Infect Dis; 2015 May; 211(10):1616-27. PubMed ID: 25489003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exogenous remodeling of lung resident macrophages protects against infectious consequences of bone marrow-suppressive chemotherapy.
    Kamei A; Gao G; Neale G; Loh LN; Vogel P; Thomas PG; Tuomanen EI; Murray PJ
    Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6153-E6161. PubMed ID: 27671632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.